Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Debt / NOTE 2.625% 2/0
-
Market price (% of par)
-
153.81%
-
Total 13F principal
-
$69,139,000
-
Principal change
-
+$180,000
-
Total reported market value
-
$106,417,775
-
Number of holders
-
29
-
Value change
-
+$1,346,829
-
Number of buys
-
10
-
Number of sells
-
15
Institutional Holders of CONMED CORP - NOTE 2.625% 2/0 as of Q2 2023
As of 30 Jun 2023,
CONMED CORP - NOTE 2.625% 2/0 was held by
29 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$69,139,000
in principal (par value) of the bond.
The largest 10 bondholders included
CAPSTONE INVESTMENT ADVISORS, LLC, WOLVERINE ASSET MANAGEMENT LLC, MACKAY SHIELDS LLC, JPMORGAN CHASE & CO, ABSOLUTE INVESTMENT ADVISERS, LLC, CITADEL ADVISORS LLC, Warberg Asset Management LLC, PALISADE CAPITAL MANAGEMENT, LP, ZAZOVE ASSOCIATES LLC, and WELLS FARGO & COMPANY/MN.
This page lists
29
institutional bondholders reporting positions
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.